1016557-47-3

Basic information

• Product Name: N-butanoyl-N'-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbonyl]-hydrazine
• Synonyms: N-butanoyl-N'-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbonyl]-hydrazine
• CAS NO: 1016557-47-3
• Molecular Weight: 465.766
• Mol File: 1016557-47-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-butanoyl-N'-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbonyl]-hydrazine(CAS DataBase Reference)
• NIST Chemistry Reference: N-butanoyl-N'-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbonyl]-hydrazine(1016557-47-3)
• EPA Substance Registry System: N-butanoyl-N'-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbonyl]-hydrazine(1016557-47-3)

Safety Data

• Hazardous Substances Data: 1016557-47-3(Hazardous Substances Data)

Upstream product

• 107-92-6 butyric acid 
• 443141-90-0 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazide 
• 3538-65-6 butyric acid hydrazide 
• 162758-35-2 rimonabant acid 

Relevant articles and documents

Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity

Since the CB1 cannabinoid receptor antagonist 1 (SR141716, rimonabant) was previously reported to modulate food intake, CB1 antagonism has been considered as a new therapeutic target for the treatment of obesity. In the present study, biarylpyrazole analo